TAGE评分用于急性缺血性卒中血管内治疗成功后再灌注后症状性颅内出血预测
本研究基于THRACE试验和2个前瞻性登记队列,纳入前循环急性缺血性卒中机械取栓成功再通患者,推导队列402例、验证队列507例,评估早期静脉充盈(EVF)是否为症状性颅内出血(sICH)的独立预测因素,并构建TAGE评分。结果显示EVF是sICH的独立预测因素(OR 11.9),TAGE评分在推导队列AUC为0.832,验证队列AUC为0.801。
要点
- 早期静脉充盈(EVF)是完全再通后症状性颅内出血的独立预测因素,OR为11.9。
- TAGE评分由发病至成功再通时间>270分钟、ASPECTS≤5或6-7、血糖>7 mmol/L和EVF构成。
- TAGE评分在验证队列预测sICH的AUC为0.801,表现良好。
核心结论
- TAGE评分是一种使用 readily available 临床变量的简单工具,在机械取栓后预测sICH方面表现良好。
研究设计与样本
- 研究纳入THRACE试验和2个前瞻性登记中连续接受机械取栓的前循环急性缺血性卒中患者,分为推导队列(中心1,n=402)和验证队列(THRACE和中心2,n=507)。
- EVF由2名盲法评估者评定,sICH根据改良欧洲急性卒中协作研究II标准定义。
主要发现
- 两个队列的症状性颅内出血率相似(分别为9.9%和8.9%,P=0.9)。
- 发病至成功再通时间>270分钟(OR 7.8,95%CI 2.5-24)、ASPECTS≤5(OR 2.49,95%CI 1.8-8.1)或6-7(OR 1.15,95%CI 1.03-4.46)、血糖>7 mmol/L(OR 2.92,95%CI 1.26-6.7)以及EVF存在(OR 11.9,95%CI 3.8-37.5)是sICH的独立预测因素。
- 在推导队列中,TAGE评分每增加1分与sICH风险增加相关(OR 1.99,95%CI 1.53-2.59;P<0.001),AUC为0.832(95%CI 0.767-0.898)。
- 在验证队列中,TAGE评分预测sICH的AUC为0.801(95%CI 0.69-0.91)。
关键数值与推荐
- TAGE评分包含:发病至成功再通时间>270分钟、ASPECTS≤5或6-7、血糖>7 mmol/L、EVF存在。
- 推导队列中TAGE评分预测sICH的AUC为0.832(95%CI 0.767-0.898),验证队列AUC为0.801(95%CI 0.69-0.91)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Determine if early venous filling (EVF) after complete successful recanalization with mechanical thrombectomy in acute ischemic stroke is an independent predictor of symptomatic intracranial hemorrhage (sICH) and integrate EVF into a risk score for sICH prediction. METHODS: Consecutive patients with anterior acute ischemic stroke treated by mechanical thrombectomy issued from patients enrolled in the THRACE trial (Thrombectomie des Artères Cérébrales) and from 2 prospective registries were included and divided into a derivation (Center I; n=402) and validation cohorts (THRACE and center 2; n=507). EVF was evaluated by 2 blinded readers. sICH was defined according to the modified European cooperative acute stroke study II. Clinical and radiological data were analyzed in the derivation cohort (C1) to identify independent predictors of sICH and construct a predictive score test on the validation cohort (THRACE + C2). RESULTS: Symptomatic ICH rate was similar between the two cohorts (9.9% and 8.9% respectively, P=0.9). Time from onset-to-successful recanalization >270 minutes (odds ratio [OR], 7.8 [95% CI, 2.5-24]), Alberta Stroke Program Early CT Score (≤5 [OR, 2.49 (95% CI, 1.8-8.1) or 6-7 [OR, 1.15 (95% CI, 1.03-4.46)]), glucose blood level >7 mmol/L (OR, 2.92 [95% CI, 1.26-6.7]), and EVF presence (OR, 11.9 [95% CI, 3.8-37.5]) were independent predictors of sICH and constituted the Time-Alberta Stroke Program Early CT-Glycemia-EVF score. Time-Alberta Stroke Program Early CT-Glycemia-EVF score was associated with an increased risk of sICH in the derivation cohort (OR increase per unit, 1.99 [95% CI, 1.53-2.59]; P<0.001) with area under the curve, 0.832 [95% CI, 0.767-0.898]. The score had good performance in the validation cohort (area under the curve, 0.801 [95% CI, 0.69-0.91]). CONCLUSIONS: Time-Alberta Stroke Program Early CT-Glycemia-EVF score is a simple tool with readily available clinical variables with good performances for sICH prediction after mechanical thrombectomy. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT01062698.
引用
- Janvier P, Kerleroux B, Turc G, et al. TAGE Score for Symptomatic Intracranial Hemorrhage Prediction After Successful Endovascular Treatment in Acute Ischemic Stroke. Stroke. 2022. PMID: 35698971. doi:10.1161/STROKEAHA.121.038088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。